Search

Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week.  Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Medicine and Professor of Cardiology at the Johns Hopkins University of Medicine in Baltimore, Maryland.

The National ICD Registry®, a repository of implantable cardioverter defibrillator (ICD) implantation data developed through a partnership of the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF), released the National ICD Registry Report: Version 2.1. The new version expands upon the 2009 Annual Report to now include data on leads and pediatric implants to reflect recent advancements in healthcare. This report is featured online in HeartRhythm, the official Journal of the Heart Rhythm Society.

As an Employer of Choice, The Heart Rhythm Society offers a robust benefit package., We are proud of our benefit offerings and believe they provide a substantial measure of security, protection and flexibility for our staff and their families, both now and in the future.

A new study shows young adults with congenital heart disease (CHD) also living with an implantable cardioverter- defibrillator (ICD) experience a high level of shock-related anxiety. The multicenter study, published in the June edition of HeartRhythm, the official journal of the Heart Rhythm Society, is the first to discover that shock-related anxiety is associated with sexual dysfunction in young adults and calls on healthcare providers to address these issues to improve the quality of life for patients.

BOSTON, May 14, 2009 — Common psychotropic medications such as antipsychotics, antidepressants and benzodiazepines, may contribute to an increased risk of sudden death during an acute coronary event, according to a new study released today at Heart Rhythm 2009, the Heart Rhythm Society’s 30th Annual Scientific Sessions. This case-control study is the first of its kind to compare psychotropic medication use in heart attack survivors and victims of sudden cardiac death.

WASHINGTON, DC — New research proves the feasibility of leadless pacing in heart failure patients with ultrasound-mediated stimulation energy. The new study published in the June edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, sought to apply ultrasound-mediated leadless pacing technology in heart failure patients and to evaluate the effects of respiration and body posture on the acoustic window. The study is the first of its kind to demonstrate successful leadless pacing in human subjects with advanced heart failure.